SCHEMBL3635774

SCHEMBL3635774

CCOc1ccccc1Nc1nccs1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.58
MAPK1 P28482 2/20 0.58
MAPK10 P53779 1/20 0.54
ALDH1A1 P00352 8/20 0.52
TDP1 Q9NUW8 3/20 0.52
KDM4E B2RXH2 1/20 0.51
MAPT P10636 1/20 0.51
KMT2A Q03164 3/20 0.48
HTT P42858 2/20 0.48
MEN1 O00255 2/20 0.48
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
PKM P14618 2/20 0.47
GAA P10253 2/20 0.47
HSD17B10 Q99714 1/20 0.47
POLB P06746 3/20 0.46
THRB P10828 1/20 0.46
CASP6 P55212 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL899473 0.84 ALDH1A1 (0.57) ALOX15MAPK1MAPK10ALDH1A1TDP1
SCHEMBL1340922 0.81 ALOX15 (0.71) ALOX15MAPK1ALDH1A1TDP1KDM4E
SCHEMBL1135241 0.79 ALDH1A1 (0.52) ALDH1A1TDP1KMT2AMEN1TP53
SCHEMBL18550722 0.78 ALDH1A1 (0.59) ALOX15MAPK1ALDH1A1TDP1KDM4E
SCHEMBL11521594 0.78 MAPK10 (0.62) ALOX15MAPK1MAPK10ALDH1A1KDM4E
SCHEMBL12136708 0.77 MAPT (0.72) MAPK10ALDH1A1TDP1KDM4EMAPT
SCHEMBL9851135 0.76 TDP1 (0.59) MAPK1MAPK10ALDH1A1TDP1KDM4E
SCHEMBL8277525 0.75 KMT2A (0.58) ALOX15MAPK1MAPK10ALDH1A1TDP1
SCHEMBL17226235 0.75 MAPT (0.56) ALOX15MAPK1MAPK10ALDH1A1TDP1
SCHEMBL3040034 0.74 NPC1 (0.60) ALOX15MAPK1ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825112-B2 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof SANOFI-AVENTIS (FR) 2010-11-02 US disclosed
US-20090018117-A1 2-CARBAMIDE-4-PHENYLTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018117-A1 2-CARBAMIDE-4-PHENYLTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF PKD2, QPCT, CCNT2 ALOX15 3509/4885MAPK1 3423/4885MAPK10 1508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.